Show simple item record

dc.contributor.authorLiu, Hui
dc.description.abstractCD8 + T cells are critical to immune control of Trypanosoma cruzi infection and targets of this response are potential vaccine candidates. In this study, we explored the utilization of HIV tat 49-57 (TAT peptide) to deliver potential CTL target proteins to the MHC class I antigen presentation pathway as a method to identify CD8 + T cell targets. Purified 'misfolded' chicken ovalbumin (OVA) fused with TAT, i.e. TAT-HA-OVA, was shown to translocate into the cytosol of the cells while HA-OVA was not. However, both TAT-HA-OVA and HA-OVA were processed and presented by MHC class I molecules for the recognition and activation of CD8 + T cells. In addition, purified TAT-HA-TSA-1 (Trypomastigote-surface-antigen-1) and HA-TSA-1 were able to activate TSA-1 specific CD8 + T cells as well. These results suggest that denatured fusion proteins, with or without TAT translocation sequence, are able to be processed and presented in association with MHC class I molecules.
dc.rightsOn Campus Only
dc.subjectExogenous proteins
dc.subjectMHC class I Antigen Presentation
dc.titleTargeting of exogenous proteins into the MHC class I antigen presentation pathway
dc.description.departmentCellular Biology
dc.description.majorCellular Biology
dc.description.advisorRick L. Tarleton
dc.description.committeeRick L. Tarleton
dc.description.committeeAnil Bamezai
dc.description.committeeHarry Dickerson

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record